Amgen Inc (AMGN)

AMGN (NASDAQ:Drugs) EQUITY
$187.46
pos +1.10
+0.61%
Today's Range: 186.08 - 188.55 | AMGN Avg Daily Volume: 2,479,800
Last Update: 09/20/17 - 12:48 PM EDT
Volume: 697,733
YTD Performance: 27.54%
Open: $186.08
Previous Close: $186.32
52 Week Range: $130.09 - $181.81
Oustanding Shares: 729,674,773
Market Cap: 136,062,454,921
6-Month Chart
TheStreet Ratings Grade for AMGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 5 5 4 3
Moderate Buy 1 1 1 1
Hold 12 12 10 10
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.36 2.36 2.37 2.46
Latest Dividend: 1.15
Latest Dividend Yield: 2.47%
Dividend Ex-Date: 08/15/17
Price Earnings Ratio: 16.98
Price Earnings Comparisons:
AMGN Sector Avg. S&P 500
16.98 17.00 36.80
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
14.81% 8.72% 31.30%
GROWTH 12 Mo 3 Yr CAGR
Revenue 6.10 0.20 0.07
Net Income 11.30 0.50 0.15
EPS 13.00 0.50 0.15
Earnings for AMGN:
EBITDA 12.03B
Revenue 22.99B
Average Earnings Estimates
Qtr (09/17) Qtr (12/17) FY (12/17) FY (12/18)
Average Estimate $3.07 $3.06 $12.48 $12.72
Number of Analysts 9 7 11 12
High Estimate $3.17 $3.16 $12.63 $13.13
Low Estimate $2.94 $2.94 $12.34 $11.70
Prior Year $3.02 $2.89 $11.65 $12.48
Growth Rate (Year over Year) 1.80% 6.03% 7.16% 1.89%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Update
Sep 15, 2017 | 7:11 AM EDT
Amgen stock coverage was initiated at RBC with a "Sector Perform" rating and a $192 price target.
We would suggest doing some buying here.
As a Miami resident, I've learned the value of hurricane preparation and the 'Jensen Rules'.
As a Florida resident, I've learned the value of preparation and the 'Jensen Rules'.
Today's breakout move in the stock is a highlight of the surging sector.
Today's breakout move in the stock is a highlight of the surging sector.
Bearish
Jul 26, 2017 | 9:05 AM EDT
Amgen was downgraded at BMO to "Market Perform" from "Outperform" with a $199 price target.

Intermediate Trade: QQQ Real Money Pro($)

Try this bearishly biased, out-of-the-money put spread on the Nasdaq 100 ETF.

Intermediate Trade: QQQ Real Money Pro($)

Consider this bearishly biased, August put spread.
The stock is set up well for more upside and remains very near a low-risk buy zone.

Columnist Conversations

The symmetry is holding up in MCD.  Target 1 is 163.34 if we continue to hold above here!  ...
As far as TSLA is concerned, I still have a higher target above the market at the 409 area.  I stated in ...
The TLT setup discussed in my last commentary is a bust. Key support was violated and it violated the recent l...
BBY is getting smoked this mornings(weak forecast).  The stock is off 8% after opening the session with a...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.